Announcements Trials

Browse Landscape

Phase

Phase NA 12 Phase 2 7 Phase 1 5 Phase 3 4 Phase 4 1

Status

Completed 4 Unknown 1 Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Polycystic Ovary Syndrome 1

Interventions

Metformin 16 Cyclophosphamide 16 Drug Therapy 14 Dexamethasone 14 Cisplatin 13 Cytarabine 11 Gemcitabine 10 Radiotherapy 9 Oxaliplatin 9 Carboplatin 9 Vincristine 8 Paclitaxel 8 Idarubicin 8 Etoposide 8 Docetaxel 8 ulipristal acetate 7 icotinib 7 Sodium Chloride 7 Methotrexate 7 Fluorouracil 7 Dexmedetomidine 7 entecavir 6 Thalidomide 6 Surgical Procedures, Operative 6 Sorafenib 6 Pemetrexed 6 Leuprolide 6 Granulocyte Colony-Stimulating Factor 6 Epirubicin 6 Doxorubicin 6

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 4 × Unknown × Therapeutics × Clear all

NCT00378729 2011-10-04

PERCING

Assistance Publique - Hôpitaux de Paris

Phase 4 Unknown

Polycystic Ovary Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon ⚡